Dhanuka Agritech Ltd
Dhanuka Agritech manufactures a wide range of agro-chemicals like herbicides, insecticides, fungicides, plant growth regulators in various forms liquid, dust, powder and granules.(Source : 202003 Annual Report Page No:93)
- Market Cap ₹ 2,806 Cr.
- Current Price ₹ 615
- High / Low ₹ 797 / 610
- Stock P/E 12.6
- Book Value ₹ 226
- Dividend Yield 2.28 %
- ROCE 30.0 %
- ROE 23.3 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 25.4%
Cons
- The company has delivered a poor sales growth of 10.8% over past five years.
- Promoter holding has decreased over last 3 years: -4.82%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
491 | 529 | 582 | 738 | 785 | 829 | 883 | 963 | 1,006 | 1,120 | 1,387 | 1,478 | 1,647 | |
415 | 450 | 500 | 618 | 653 | 689 | 713 | 796 | 860 | 947 | 1,118 | 1,214 | 1,381 | |
Operating Profit | 76 | 80 | 82 | 121 | 132 | 140 | 170 | 166 | 146 | 174 | 269 | 264 | 266 |
OPM % | 15% | 15% | 14% | 16% | 17% | 17% | 19% | 17% | 15% | 15% | 19% | 18% | 16% |
3 | 1 | 7 | 5 | 6 | 13 | 18 | 16 | 21 | 25 | 34 | 34 | 42 | |
Interest | 6 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
Depreciation | 5 | 5 | 5 | 5 | 6 | 6 | 15 | 14 | 12 | 16 | 15 | 16 | 17 |
Profit before tax | 67 | 70 | 81 | 116 | 129 | 145 | 172 | 167 | 154 | 181 | 285 | 278 | 288 |
Tax % | 24% | 18% | 20% | 20% | 18% | 26% | 29% | 24% | 27% | 22% | 26% | 25% | |
Net Profit | 51 | 57 | 64 | 93 | 106 | 107 | 122 | 126 | 113 | 141 | 211 | 209 | 223 |
EPS in Rs | 10.22 | 11.42 | 12.88 | 18.62 | 21.21 | 21.45 | 24.83 | 25.71 | 23.66 | 29.71 | 45.21 | 44.85 | 47.79 |
Dividend Payout % | 20% | 19% | 22% | 21% | 6% | 30% | 2% | 21% | 3% | 40% | 4% | 31% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 11% |
3 Years: | 14% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | 11% |
3 Years: | 23% |
TTM: | 10% |
Stock Price CAGR | |
---|---|
10 Years: | 18% |
5 Years: | 2% |
3 Years: | 24% |
1 Year: | -14% |
Return on Equity | |
---|---|
10 Years: | 24% |
5 Years: | 22% |
3 Years: | 24% |
Last Year: | 23% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10 | 10 | 10 | 10 | 3 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | |
Reserves | 160 | 205 | 253 | 322 | 410 | 470 | 512 | 624 | 633 | 698 | 787 | 951 | 1,046 |
72 | 46 | 34 | 39 | 16 | 8 | 8 | 5 | 22 | 8 | 48 | 32 | 40 | |
115 | 135 | 124 | 145 | 166 | 169 | 185 | 185 | 171 | 217 | 286 | 320 | 353 | |
Total Liabilities | 358 | 396 | 420 | 517 | 594 | 657 | 715 | 823 | 835 | 932 | 1,131 | 1,312 | 1,448 |
38 | 39 | 63 | 67 | 70 | 133 | 138 | 131 | 117 | 117 | 167 | 159 | 158 | |
CWIP | 1 | 0 | 1 | 22 | 38 | 0 | 0 | 0 | 1 | 4 | 8 | 48 | 90 |
Investments | -0 | 15 | 8 | 1 | 47 | 92 | 66 | 182 | 120 | 159 | 278 | 336 | 180 |
319 | 341 | 348 | 427 | 438 | 431 | 510 | 510 | 597 | 652 | 679 | 769 | 1,020 | |
Total Assets | 358 | 396 | 420 | 517 | 594 | 657 | 715 | 823 | 835 | 932 | 1,131 | 1,312 | 1,448 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-14 | 59 | 47 | 33 | 110 | 140 | 63 | 138 | 13 | 162 | 231 | 104 | |
-4 | -20 | -18 | -19 | -70 | -66 | 20 | -111 | 63 | -44 | -127 | -43 | |
21 | -35 | -31 | -17 | -38 | -76 | -81 | -20 | -87 | -93 | -129 | -61 | |
Net Cash Flow | 3 | 4 | -3 | -3 | 2 | -2 | 3 | 7 | -10 | 25 | -25 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 102 | 104 | 94 | 84 | 90 | 82 | 76 | 79 | 79 | 79 | 64 | 70 |
Inventory Days | 159 | 148 | 153 | 168 | 161 | 125 | 222 | 147 | 137 | 141 | 137 | 148 |
Days Payable | 58 | 58 | 43 | 38 | 52 | 46 | 48 | 60 | 51 | 64 | 50 | 74 |
Cash Conversion Cycle | 203 | 194 | 204 | 214 | 199 | 160 | 250 | 166 | 165 | 156 | 151 | 143 |
Working Capital Days | 138 | 130 | 135 | 137 | 120 | 116 | 141 | 124 | 153 | 127 | 107 | 113 |
ROCE % | 30% | 30% | 36% | 33% | 31% | 34% | 29% | 23% | 26% | 36% | 30% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 1d
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
17 Feb - Transcript of Conference Call held on 10th February, 2023 with Analysts/ Investors to discuss Un-Audited Standalone & Consolidated Financial Results of the Company for the …
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Feb - Publication copy of Un-Audited Standalone & Consolidated Financial Results for the Quarter and Nine Months Ended on 31st December, 2022.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
10 Feb - Listing Obligation and Disclosures Requirement) Regulations, 2015, please find below the link to the audio recording of the Analysts/Investors Call on the Un-Audited Standalone and …
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
10 Feb - Press Release with regard to the Un-Audited Financial Results of the Company for the Quarter and Nine Months ended on December 31, 2022
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
May 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Apr 2020TranscriptPPT
-
Feb 2020TranscriptPPT
-
Jul 2019TranscriptPPT
-
Feb 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
Product Portfolio
The Co. has 300+ product registrations across Herbicides, Insecticides, Fungicides and Plant growth regulators. About 90 Products across all segments. [1]